AbCellera Biologics Inc logo

AbCellera Biologics Inc

FRA:8QQ (Canada)   Ordinary Shares
€ 2.58 (+0.12%) Dec 20
At Loss
P/B:
0.81
Market Cap:
€ 826.91M ($ 860.70M)
Enterprise V:
€ 278.74M ($ 290.13M)
Volume:
3.00K
Avg Vol (2M):
1.71K
Trade In:
Volume:
3.00K
At Loss

Business Description

AbCellera Biologics Inc logo
AbCellera Biologics Inc
NAICS : 541714 SIC : 3741
ISIN : CA00288U1066

Share Class Description:

FRA:8QQ: Ordinary Shares
Description
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
Name Current Vs Industry Vs History
Cash-To-Debt 9.01
Equity-to-Asset 0.77
Debt-to-Equity 0.07
Debt-to-EBITDA -0.35
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.93
Distress
Grey
Safe
Beneish M-Score -3.01
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 35.09
9-Day RSI 40.87
14-Day RSI 45.08
6-1 Month Momentum % -8.31
12-1 Month Momentum % -50.89

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.34
Quick Ratio 9.34
Cash Ratio 8.08
Days Sales Outstanding 376.42

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.6
Shareholder Yield % 1.03

Financials (Next Earnings Date:2025-02-20 Est.)

FRA:8QQ's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

AbCellera Biologics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 30.241
EPS (TTM) (€) -0.559
Beta 1.31
Volatility % 54.68
14-Day RSI 45.08
14-Day ATR (€) 0.103865
20-Day SMA (€) 2.7328
12-1 Month Momentum % -50.89
52-Week Range (€) 2.16 - 5.432
Shares Outstanding (Mil) 295.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AbCellera Biologics Inc Filings

Filing Date Document Date Form
No Filing Data

AbCellera Biologics Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

AbCellera Biologics Inc Frequently Asked Questions

What is AbCellera Biologics Inc(FRA:8QQ)'s stock price today?
The current price of FRA:8QQ is €2.58. The 52 week high of FRA:8QQ is €5.43 and 52 week low is €2.16.
When is next earnings date of AbCellera Biologics Inc(FRA:8QQ)?
The next earnings date of AbCellera Biologics Inc(FRA:8QQ) is 2025-02-20 Est..
Does AbCellera Biologics Inc(FRA:8QQ) pay dividends? If so, how much?
AbCellera Biologics Inc(FRA:8QQ) does not pay dividend.

Press Release

Subject Date
No Press Release